Altre lingue PeptiDream Inc.

Azioni

4587

JP3836750004

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 31/05/2024			Variaz. 5gg	Var. 1 gen.
1.969 ^JPY	+0,03%		+1,68%	+32,46%

14/05	Peptidream Inc. rivede le previsioni di guadagno consolidato per l'anno fiscale che terminerà il 31 dicembre 2024	CI
30/04	Peptidream annuncia l'ampliamento della collaborazione per la scoperta di peptidi con Novartis	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Peptidream Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	14/05
Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis	30/04
PeptiDream Inc. Announces Expansion of Peptide Discovery Collaboration with Novartis Pharma AG	30/04
PeptiDream Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	14/02
PeptiDream Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
PEPTIDREAM INC. : Jefferies & Co. toujours neutre sur le dossier	24/01
PeptiDream Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	09/11
PEPTIDREAM INC. : Jefferies & Co. moins optimiste	27/10/23
Peptidream Announces Update on PDL1 Program Partnered with Bristol-Myers Squibb Company	26/10/23
PEPTIDREAM INC. : Jefferies & Co. relève sa recommandation à acheter	18/10/23
PeptiDream Inc. Announces Collaboration and License Agreement with Genentech for the Discovery and Development of Novel Peptide- Radioisotope Drug Conjugates	20/09/23
RayzeBio, Inc. has completed an IPO in the amount of $310.9968 million.	14/09/23
PeptiDream Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	09/08/23
PeptiDream Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	09/08/23
Astellas Pharma Inc. and PeptiDream Inc. Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders	25/07/23
PEPTIDREAM INC. : Jefferies & Co. moins optimiste	18/07/23
PeptiDream Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
PeptiDream Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	11/05/23
PeptiDream Inc. Announces Nomination of Second Peptide Radiopharmaceutical Therapeutic Development Candidate	22/03/23
Ono Enters into A Drug Discovery Collaboration Agreement with Peptidream to Discover and Develop Macrocyclic Constrained Peptide Therapeutics	14/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue PeptiDream Inc.

Azioni

4587

JP3836750004

Altre lingue

Filtri